Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.pfizer.com › pfizer-biontech-covid-19-vaccine-comirnatyr-receives-fullPfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S....

   www.pfizer.com › pfizer-biontech-covid-19-vaccine-comirnatyr-receives-full

   • Zapisane w pamięci cache

   11 gru 2020 · COMIRNATY ® (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine made by Pfizer for BioNTech. It is approved as a 2-dose series for prevention of COVID-19 in individuals 16 years of age and older. It is also authorized under Emergency Use Authorization (EUA) to be administered for emergency use to:

   • View PDF

     either COMIRNATY® (COVID-19 Vaccine, mRNA) or the...

   • Vaccines Manufacturing B-roll Video

     This information—including product information—is intended...

2. en.wikipedia.org › wiki › Pfizer–BioNTech_COVID-19_vaccinePfizer–BioNTech COVID-19 vaccine - Wikipedia

   en.wikipedia.org › wiki › Pfizer–BioNTech_COVID-19_vaccine

   • Zapisane w pamięci cache

   The Pfizer–BioNTech COVID-19 vaccine is used to provide protection against COVID-19, caused by infection with the SARS-CoV-2 virus, by eliciting an immune response to the S antigen. [ 1 ] [ 2 ] [ 31 ] [ 40 ] The vaccine is used to reduce morbidity and mortality from COVID-19.

3. www.who.int › publications › mPfizer-BioNTech COVID-19 Vaccine, COMIRNATY® (Tozinameran)

   www.who.int › publications › m

   • Zapisane w pamięci cache

   This vaccine resource provides key vaccine-specific information for the Pfizer-BioNTech COVID-19 Vaccine Comirnaty®, a messenger RNA (mRNA) based vaccine against coronavirus disease (COVID-19). This document has been updated in English: version 03 June 2022.

4. www.fda.gov › news-events › press-announcementsFDA Approves and Authorizes Updated mRNA COVID-19 Vaccines to...

   www.fda.gov › news-events › press-announcements

   • Zapisane w pamięci cache

   22 sie 2024 · The updated mRNA COVID-19 vaccines include Comirnaty and Spikevax, both of which are approved for individuals 12 years of age and older, and the Moderna COVID-19 Vaccine and Pfizer-BioNTech...

5. www.pfizer.com › pfizer-and-biontech-announce-omicron-adapted-covid-19Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine ...

   www.pfizer.com › pfizer-and-biontech-announce-omicron-adapted-covid-19

   • Zapisane w pamięci cache

   25 cze 2022 · COMIRNATY® (COVID-19 Vaccine, mRNA) is a vaccine approved for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older. COMIRNATY® is administered as a 2-dose primary series.

6. labeling.pfizer.com › ShowLabelingVACCINE INFORMATION FACT SHEET FOR RECIPIENTS AND CAREGIVERS ......

   labeling.pfizer.com › ShowLabeling

   COMIRNATY (COVID-19 Vaccine, mRNA) and the Pfizer-BioNTech COVID-19 Vaccine have been shown to prevent COVID-19. FDA has authorized Pfizer-BioNTech COVID-19 Vaccine, Bivalent to provide better protection against COVID-19 caused by the Omicron variant of SARS-CoV-2.

7. www.cdc.gov › vaccines › phpPfizer COVID-19 Vaccine Summary | Vaccines & Immunizations | CDC

   www.cdc.gov › vaccines › php

   • Zapisane w pamięci cache

   28 sie 2024 · Pfizer-BioNTech COVID-19 Vaccine is indicated for individuals 5 through 11 years of age (via a 10mcg / 0.3mL single-dose vial presentation) and for individuals 6 months through 4 years of age (via a 3mcg / 0.3mL multi-dose vial (3 doses per vial) presentation).